We believe…

… that every human being should have access to the information, care and treatment they need to keep their heart healthy, regardless of race, nationality, gender, age, education or income.

Our Vision

To provide support, education and advocacy for individuals and families with FH.

Our Purpose

To build Australia-wide awareness, understanding and access to diagnosis and treatments for individuals and families with FH.

Lipoprotein(a) – Lp(a)

Lipoprotein(a), or Lp(a), is a type of lipoprotein similar to LDL (“bad” cholesterol) and, if elevated, is considered an independent risk factor for cardiovascular disease (CVD). Like LDL, elevated Lp(a) can contribute to the buildup of plaque in the arteries — a process known as atherosclerosis. Over time, this narrowing of the arteries can increase the risk of heart attacks and strokes.

Key facts about Lp(a):

• Genetic & Inherited: Elevated Lp(a) is primarily determined by genetics. If you have high levels, there’s a 50% chance that your first-degree relatives (parents, siblings, children) will as well.
• Prevalence: Approximately 1 in 5 people have elevated Lp(a) levels, but the majority are unaware, as it’s not part of routine lipid testing.
• Consistent Over Time: Unlike LDL cholesterol, which can fluctuate with lifestyle and medications, Lp(a) levels are relatively stable throughout life.
• Common in Familial Hypercholesterolemia (FH): It’s especially important to check Lp(a) levels in people with familial hypercholesterolemia, as having both conditions compounds the risk of premature cardiovascular disease.